Buy Stocks Easy | About Us
January 26, 2022
Buy Stocks Easy | Online Stocks

BLPH


Buy Bellerophon Therapeutics, Inc. Stock (symbol: BLPH) Easy Online

Company Name: Bellerophon Therapeutics, Inc.

Symbol: BLPH

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2015

BLPH Current Share Price

Today's BLPH ( Bellerophon Therapeutics, Inc. ) opening price: $0.3301

Yesterday's BLPH ( Bellerophon Therapeutics, Inc. ) closing price: $0.3452

Bellerophon Therapeutics, Inc. Stock ( symbol: BLPH ) Price Chart since IPO (2015):

12 Months Bellerophon Therapeutics, Inc. Stock ( symbol: BLPH ) Price Chart

Popular Questions about Bellerophon Therapeutics, Inc. Public Stock ( BLPH )

A: Bellerophon Therapeutics, Inc. stock symbol (also called stock or share ticker) is BLPH

A: Bellerophon Therapeutics, Inc. IPO (Initial Public Offering) took place on 2015

A: Bellerophon Therapeutics, Inc.'s stock (BLPH symbol) price at ther IPO (initial Public Offering) was $0.3301

Q: Is BLPH stock worth buying at the moment?

A: The BLPH stock performance since 2019 are rather disappointing. If you had bought 1 share of Bellerophon Therapeutics, Inc. stock (symbol: BLPH) at the beginning of 2019, at the opening share price of $0.7081, you would be left with exactly $0.3301 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Bellerophon Therapeutics, Inc. Stock Easy Online

Bellerophon Therapeutics, Inc. Stock Ticker Price Chart since IPO:





Bellerophon Therapeutics, Inc. Stock Price Yesterday



 


Bellerophon Therapeutics, Inc. Stock Price – Last Week




 


Bellerophon Therapeutics, Inc. Stock Price – Last Month




 


Bellerophon Therapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            https://www.marketwatch.com/story/bellerophon-stock-is-up-35-on-hypertension-trial-data-2019-12-17
                            

                                
Bellerophon stock is up 35% on hypertension trial data

                                
                                
Shares of Bellerophon Therapeutics Inc. BLPH, +2.03% gained 38% in ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/17/1961471/0/en/Bellerophon-Announces-Positive-Top-line-Results-from-Cohort-2-of-Phase-2-3-Study-of-INOpulse-for-Treatment-of-Pulmonary-Hypertension-Associated-with-Interstitial-Lung-Disease.html
                            

                                
Bellerophon Announces Positive Top-line Results from Cohort 2 of Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

                                
                                
Statistically Significant Improvement Demonstrated in  Moderate to ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/12/1945382/0/en/Bellerophon-Announces-Positive-Initial-Data-from-Acute-Hemodynamic-Dose-Escalation-Study-of-INOpulse-for-Treatment-of-Pulmonary-Hypertension-Associated-with-Interstitial-Lung-Disea.html
                            

                                
Bellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

                                
                                
WARREN, N.J., Nov.  12, 2019  (GLOBE NEWSWIRE) -- Bellerophon Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/07/1943141/0/en/Bellerophon-Presents-New-Data-from-Cohort-1-of-Ongoing-Phase-2-3-Study-of-INOpulse-for-Treatment-of-Pulmonary-Hypertension-Associated-with-Interstitial-Lung-Disease-at-Pulmonary-Fi.html
                            

                                
Bellerophon Presents New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at Pulmonary Fibrosis Foundation Summit 2019

                                
                                
Data Include New Results from Subgroup Analysis of Cohort 1 Further...


                            

                        
                    

                


                            

                    


                        
                            http://www.gurufocus.com/news/974222/largest-insider-trades-of-the-week
                            

                                
Largest Insider Trades of the Week (Nov 01)

                                
                                
According to these filters, the following are significant trades fr...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/23/1934080/0/en/Bellerophon-Presents-New-Positive-Data-from-Cohort-1-of-Ongoing-Phase-2-3-Study-of-INOpulse-for-Treatment-of-Pulmonary-Hypertension-Associated-with-Interstitial-Lung-Disease-at-CHE.html
                            

                                
Bellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting

                                
                                
Results Presented in Late-Breaking Abstract as an Oral Presentation...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/14/1929166/0/en/Bellerophon-to-Present-New-Data-from-Cohort-1-of-Ongoing-Phase-2-3-Study-of-INOpulse-for-Treatment-of-Pulmonary-Hypertension-Associated-with-Interstitial-Lung-Disease-at-CHEST-2019.html
                            

                                
Bellerophon to Present New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting

                                
                                
Results to be Presented in Late-Breaking Abstract as an Oral Presen...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/16/1915929/0/en/Bellerophon-Receives-Orphan-Drug-Designation-for-Nitric-Oxide-in-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis.html
                            

                                
Bellerophon Receives Orphan Drug Designation for Nitric Oxide in the Treatment of Idiopathic Pulmonary Fibrosis

                                
                                
WARREN, N.J., Sept.  16, 2019  (GLOBE NEWSWIRE) -- Bellerophon Ther...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/04/1910786/0/en/Bellerophon-to-Present-at-the-H-C-Wainwright-21st-Annual-Global-Investment-Conference.html
                            

                                
Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference

                                
                                
WARREN, N.J., Sept.  04, 2019  (GLOBE NEWSWIRE) -- Bellerophon Ther...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.